China Isotope & Radiation Corporation (HKG:1763)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Nuclear Medicines	4.02B	4.17B	4.13B	3.93B	3.76B
Nuclear Medicines Growth	-3.62%	0.94%	5.28%	4.53%	26.00%
Radioactive Source Products	835.65M	745.81M	638.08M	618.44M	554.83M
Radioactive Source Products Growth	12.05%	16.88%	3.18%	11.46%	17.71%
Irradiation	191.30M	200.33M	178.56M	171.33M	144.25M
Irradiation Growth	-4.51%	12.20%	4.22%	18.77%	40.48%
Nuclear Medical Equipment and Related Services	601.55M	1.23B	940.71M	739.98M	404.22M
Nuclear Medical Equipment and Related Services Growth	-51.15%	30.90%	27.13%	83.06%	72.86%
Other Businesses	1.60B	1.31B	816.48M	755.24M	-
Other Businesses Growth	22.67%	59.93%	8.11%	-	-
Elimination of Inter-Segment	-62.82M	-79.67M	-71.10M	-56.49M	-52.36M
Independent Clinical Medical and Laboratory Services and Other Businesses (Excluding Radiation Therapy Equipments and Related Services)	-	-	-	-	337.72M
Independent Clinical Medical and Laboratory Services and Other Businesses (Excluding Radiation Therapy Equipments and Related Services) Growth	-	-	-	-	-33.95%
Total	7.19B	7.57B	6.63B	6.15B	5.14B
Total Growth	-5.11%	14.16%	7.82%	19.63%	20.34%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
People's Republic of China (PRC)	7.19B	7.57B	6.63B	6.15B	5.14B
People's Republic of China (PRC) Growth	-5.11%	14.16%	7.82%	19.63%	20.34%
Total	7.19B	7.57B	6.63B	6.15B	5.14B
Total Growth	-5.11%	14.16%	7.82%	19.63%	20.34%

Source: S&P Global Market Intelligence.